An exploratory metabolomic comparison of participants with fast or absent functional progression from 2CARE, a randomized, double-blind clinical trial in Huntington's disease.

Pooled analysis Metabolites with nominally significant differences (p<0.05) and trends (0.05<p<0.10) between screening and Year 3 within the FP and AP groups Metabolites that were nominally different are reported in Table 2 with circulating concentrations reported in Table S1.

also in 7,732 other papers